| MDMA | Q69488 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00210-016-1297-4 |
| P698 | PubMed publication ID | 27650729 |
| P2093 | author name string | David Nutt | |
| Jakob A Shimshoni | |||
| Ezekiel Golan | |||
| Ilan Winkler | |||
| P2860 | cites work | Psychedelics and the human receptorome | Q21090031 |
| Exit mechanisms of the intracellular bacterium Ehrlichia | Q21091072 | ||
| The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study | Q24606265 | ||
| Imaging DA release in a rat model of L-DOPA-induced dyskinesias: a longitudinal in vivo PET investigation of the antidyskinetic effect of MDMA. | Q47415585 | ||
| MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac). | Q48099202 | ||
| Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation. | Q48114166 | ||
| Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex | Q48362414 | ||
| Subjective reports of the effects of MDMA in a clinical setting. | Q51207935 | ||
| Four fatalities involving 5-IT. | Q51223844 | ||
| Purification and properties of mitochondrial monoamine oxidase type A from human placenta | Q69969207 | ||
| Studies with synthetic peptide substrates derived from the neuronal protein neurogranin reveal structural determinants of potency and selectivity for protein kinase C | Q70540482 | ||
| Regions of the molecule responsible for substrate specificity of monoamine oxidase A and B: a chimeric enzyme analysis | Q71372501 | ||
| Neurobiology of posttraumatic stress disorder | Q83237759 | ||
| Emerging drugs of abuse | Q86842686 | ||
| PKCα is genetically linked to memory capacity in healthy subjects and to risk for posttraumatic stress disorder in genocide survivors | Q24614975 | ||
| Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA) | Q24619949 | ||
| Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study | Q24620135 | ||
| Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells | Q24675490 | ||
| Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin | Q28143430 | ||
| Monoamine neurocircuitry in depression and strategies for new treatments | Q30619239 | ||
| Predicting ADME properties and side effects: the BioPrint approach. | Q31155695 | ||
| Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study | Q33956204 | ||
| An exploration of the history and controversies surrounding MDMA and MDA. | Q34102744 | ||
| Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity. | Q34149598 | ||
| A Clinical Plan for MDMA (Ecstasy) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA | Q34190116 | ||
| Short- and long-term effects of MDMA (“ecstasy”) on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo | Q34196259 | ||
| 6.7-Dihydroxycoumarin (Aesculetin) as a substrate for catechol-o-methyltransferase (author's transl) | Q34241742 | ||
| A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). | Q34309474 | ||
| Neurochemical profiles of some novel psychoactive substances | Q34319162 | ||
| 5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO). | Q34377010 | ||
| A meta-analytic clarification of the relationship between posttraumatic growth and symptoms of posttraumatic distress disorder | Q34388894 | ||
| Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. | Q34976260 | ||
| Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. | Q34989613 | ||
| Monoamine transporters and psychostimulant drugs | Q35581483 | ||
| α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief | Q36517174 | ||
| Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies | Q37231098 | ||
| Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine | Q37307278 | ||
| Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands | Q37331831 | ||
| Emerging treatments for PTSD. | Q37607693 | ||
| Protein kinase Calpha: disease regulator and therapeutic target. | Q37647208 | ||
| New phenethylamines in Europe | Q38191529 | ||
| Prevalence of use and acute toxicity associated with the use of NBOMe drugs | Q38346439 | ||
| Mind-altering drugs and research: from presumptive prejudice to a Neuroscientific Enlightenment?: Science & Society series on "Drugs and Science" | Q38798504 | ||
| Can drugs be used to enhance the psychotherapeutic process? | Q39238111 | ||
| MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. | Q40028400 | ||
| MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. | Q40362823 | ||
| Pharmacological profile of hypericum extract. Effect on serotonin uptake by postsynaptic receptors | Q40966330 | ||
| The effects of 3,4-methylenedioxymethamphetamine (MDMA) on nicotinic receptors: intracellular calcium increase, calpain/caspase 3 activation, and functional upregulation | Q42466857 | ||
| A cluster of deaths involving 5-(2-aminopropyl)indole (5-IT). | Q44024244 | ||
| Conversion of L-tyrosine to 3,4-dihydroxyphenylalanine by cell-free preparations of brain and sympathetically innervated tissues | Q46778622 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 15-24 | |
| P577 | publication date | 2016-09-20 | |
| P1433 | published in | Naunyn-Schmiedeberg's Archives of Pharmacology | Q1468251 |
| P1476 | title | Neurochemical binding profiles of novel indole and benzofuran MDMA analogues. | |
| P478 | volume | 390 |
| Q47342074 | Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium. |
| Q58612229 | Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters |
| Q94558018 | Syntheses and analytical characterizations of novel (2-aminopropyl)benzo[b]thiophene (APBT) based stimulants |
Search more.